Saturday 22 November 2003
UI:254 - Atherosclerosis - recanalization
UI:390 - Atherosclerosis with fatty streak
UI:614 - Atherosclerosis: Cholesterol clefts
UI:677 - Atherosclerosis: Cholesterol clefts and dystrophic calcifiction
UI:716: Thrombus on Atherosclerotic plaque
Definition: Atherosclerosis is a ’narrowing’ or hardening of the arteries by fibrosis of the vascular wall caused by atheroma.
Itis a pathological process that involves the progressive expansion of lesions (plaques) that reduce blood flow in arteries.
Atherosclerosis is a condition in which an artery wall thickens as a result of the accumulation of fatty materials such as cholesterol.
It is a syndrome affecting arterial blood vessels, a chronic inflammatory response in the walls of arteries, caused largely by the accumulation of macrophage white blood cells and promoted by low-density lipoproteins (LDL, plasma proteins that carry cholesterol and triglycerides) without adequate removal of fats and cholesterol from the macrophages by functional high-density lipoproteins (HDL), (see apoA-1 Milano).
It is commonly referred to as a hardening or furring of the arteries. It is caused by the formation of multiple plaques within the arteries.
arteriosclerosis (also known as arteriosclerotic vascular disease or ASVD)
Major AS, Joyce S, Van Kaer L. Lipid metabolism, atherogenesis and CD1-restricted antigen presentation. Trends Mol Med. 2006 Jun;12(6):270-8. PMID: #16651026#
Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005 Apr 21;352(16):1685-95. PMID: #15843671#
Xu Q. Mouse models of arteriosclerosis: from arterial injuries to vascular grafts. Am J Pathol. 2004 Jul;165(1):1-10. PMID: #15215157#
Scott J. Pathophysiology and biochemistry of cardiovascular disease. Curr Opin Genet Dev. 2004 Jun;14(3):271-9. PMID: #15172670#
Boisvert WA. Modulation of atherogenesis by chemokines. Trends Cardiovasc Med. 2004 May;14(4):161-5. PMID: #15177267#
Kutuk O, Basaga H. Inflammation meets oxidation: NF-kappaB as a mediator of initial lesion development in atherosclerosis. Trends Mol Med. 2003 Dec;9(12):549-57. PMID: #14659470#
de Nigris F, Lerman A, Ignarro LJ, Williams-Ignarro S, Sica V, Baker AH, Lerman LO, Geng YJ, Napoli C. Oxidation-sensitive mechanisms, vascular apoptosis and atherosclerosis. Trends Mol Med. 2003 Aug;9(8):351-9. PMID: #12928037#
Albertini R, Moratti R, De Luca G. Oxidation of low-density lipoprotein in atherosclerosis from basic biochemistry to clinical studies. Curr Mol Med. 2002 Sep;2(6):579-92. PMID: #12243250#
Duval C, Chinetti G, Trottein F, Fruchart JC, Staels B. The role of PPARs in atherosclerosis. Trends Mol Med. 2002 Sep;8(9):422-30. PMID: #12223313#
Ursini F, Davies KJ, Maiorino M, Parasassi T, Sevanian A. Atherosclerosis: another protein misfolding disease? Trends Mol Med. 2002 Aug;8(8):370-4. PMID: #12127722#
Boerwinkle E, Ellsworth DL, Hallman DM, Biddinger A. Genetic analysis of atherosclerosis: a research paradigm for the common chronic diseases. Hum Mol Genet. 1996;5 Spec No:1405-10. PMID: #8875244#